Nantahala Capital Management, LLC Centessa Pharmaceuticals PLC Transaction History
Nantahala Capital Management, LLC
- $2.22 Billion
- Q1 2025
A detailed history of Nantahala Capital Management, LLC transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Nantahala Capital Management, LLC holds 554,803 shares of CNTA stock, worth $7.18 Million. This represents 0.36% of its overall portfolio holdings.
Number of Shares
554,803
Previous 512,647
8.22%
Holding current value
$7.18 Million
Previous $8.59 Million
7.08%
% of portfolio
0.36%
Previous 0.43%
Shares
3 transactions
Others Institutions Holding CNTA
# of Institutions
142Shares Held
124MCall Options Held
163KPut Options Held
816K-
Medicxi Ventures Management (Jersey) LTD20MShares$259 Million75.25% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$129 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$125 Million4.7% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.95MShares$90.1 Million0.19% of portfolio
-
Janus Henderson Group PLC London, X05.92MShares$76.7 Million0.05% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.22B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...